Authors

• Petr Cetkovský
• Štěpán Hrabovský (ORCID: https://orcid.org/0000-0003-4820-4267)
• Cyril Šálek (ORCID: https://orcid.org/0000-0002-0021-3247)
• Jan Trka (ORCID: https://orcid.org/0000-0002-9527-8608)
• Leona Reznickova
• Eva Fronkova
• Michael Doubek (ORCID: https://orcid.org/0000-0002-1269-6282)
• Zdeněk Kořı́stek (ORCID: https://orcid.org/0000-0002-0478-854X)
• Václava Polívková (ORCID: https://orcid.org/0000-0001-6583-0425)
• Pavla Pecherková (ORCID: https://orcid.org/0000-0002-5593-886X)
• Jitka Křížková
• Kateřina Machová Poláková (ORCID: https://orcid.org/0000-0002-7398-5555)
• František Folber (ORCID: https://orcid.org/0000-0001-7034-769X)
• Jan M. Horáček (ORCID: https://orcid.org/0000-0002-4077-3097)
• Petr Soukup (ORCID: https://orcid.org/0000-0001-9241-6529)
• Zuzana Vrzalová (ORCID: https://orcid.org/0000-0002-1282-6956)
• Hana Halamova
• Barbora Dluhošová (ORCID: https://orcid.org/0009-0003-8095-7928)

Institutions

• Central European Institute of Technology (CZ)
• University of Ostrava (CZ)
• Charles University (CZ)
• Masaryk University (CZ)
• University Hospital Ostrava (CZ)
• Institute of Haematology and Blood Transfusion (CZ)
• University Hospital Hradec Králové (CZ)
• University of Defence (RS)

Publication Details

Journal

Haematologica

Published

2025-02-13

DOI

https://doi.org/10.3324/haematol.2024.287062

Primary Topic

Acute Lymphoblastic Leukemia research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Pfizer
• AstraZeneca
• Gilead Sciences
• CSL Behring
• Astellas Pharma
• AOP Orphan
• Kite Pharma